CONSTELLATION PHARMACEUTICALS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Revenue
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Interest income
Gain on disposal of equipment
Loss on extinguishment of debt
Interest expense
Total other income (expense), net
Loss before income taxes
Income tax expense
Net loss
Unrealized gain (loss) on marketable securities
Total other comprehensive gain (loss)
Comprehensive loss
Net loss per share attributable to common stockholders, basic and diluted
Weighted average common shares outstanding, basic and diluted

Comments